BETA


2014/2759(DEA) Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use

Progress: Procedure completed - delegated act enters into force

RoleCommitteeRapporteurShadows
Lead ENVI
Lead committee dossier:

Events

2015/10/05
   EC - Document attached to the procedure
Documents
2015/07/06
   EC - Document attached to the procedure
Documents
2014/11/25
   EP - Delegated act not objected by Parliament
2014/09/17
   EP - Committee referral announced in Parliament, 1st reading/single reading
2014/09/16
   EP/CSL - Initial period for examining delegated act extended at Parliament's request by 2 month(s)
2014/07/17
   EP/CSL - Initial period for examining delegated act 2 month(s)
2014/05/28
   EC - Non-legislative basic document
Documents
2014/05/28
   EC - Non-legislative basic document published
Documents

Documents

  • Document attached to the procedure: C(2015)6791
  • Document attached to the procedure: C(2015)4742
  • Non-legislative basic document: C(2014)03446
  • Non-legislative basic document published: C(2014)03446
  • Non-legislative basic document: C(2014)03446
  • Document attached to the procedure: C(2015)4742
  • Document attached to the procedure: C(2015)6791

History

(these mark the time of scraping, not the official date of the change)

docs/0/docs/0/url
https://webgate.ec.europa.eu/regdel/web/delegatedActsLinks/C(2014)03446
events/0/docs/0/url
https://webgate.ec.europa.eu/regdel/web/delegatedActsLinks/C(2014)03446
procedure/stage_reached
Old
Awaiting Council decision on delegated act
New
Procedure completed - delegated act enters into force
committees/0/date
    activities
    • date: 2014-05-28T00:00:00 docs: type: Non-legislative basic document published title: C(2014)03446 body: EC commission: type: Non-legislative basic document published
    • date: 2014-07-17T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s)
    • date: 2014-09-16T00:00:00 body: EP/CSL type: Initial period for examining delegated act extended at Parliament's request by 2 month(s)
    • date: 2014-09-17T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
    • date: 2014-11-25T00:00:00 body: EP/CSL type: Delegated act not objected by Parliament
    committees/0
    type
    Responsible Committee
    body
    EP
    associated
    False
    committee_full
    Environment, Public Health and Food Safety
    committee
    ENVI
    date
    committees/0
    body
    EP
    responsible
    True
    committee_full
    Environment, Public Health and Food Safety
    committee
    ENVI
    docs
    • date: 2014-05-28T00:00:00 docs: title: C(2014)03446 type: Non-legislative basic document body: EC
    • date: 2015-07-06T00:00:00 docs: title: C(2015)4742 type: Document attached to the procedure body: EC
    • date: 2015-10-05T00:00:00 docs: title: C(2015)6791 type: Document attached to the procedure body: EC
    events
    • date: 2014-05-28T00:00:00 type: Non-legislative basic document published body: EC docs: title: C(2014)03446
    • date: 2014-07-17T00:00:00 type: Initial period for examining delegated act 2 month(s) body: EP/CSL
    • date: 2014-09-16T00:00:00 type: Initial period for examining delegated act extended at Parliament's request by 2 month(s) body: EP/CSL
    • date: 2014-09-17T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
    • date: 2014-11-25T00:00:00 type: Delegated act not objected by Parliament body: EP
    links
    other
      procedure/dossier_of_the_committee
      Old
      ENVI/8/00856
      New
      • ENVI/8/00856
      procedure/subject
      Old
      • 4.20.04 Pharmaceutical products and industry
      New
      4.20.04
      Pharmaceutical products and industry
      procedure/summary
      • Supplementing
      activities/4
      date
      2014-11-25T00:00:00
      body
      EP/CSL
      type
      Delegated act not objected by Parliament
      procedure/stage_reached
      Old
      Awaiting committee decision
      New
      Awaiting Council decision on delegated act
      activities
      • date: 2014-05-28T00:00:00 docs: type: Non-legislative basic document published title: C(2014)03446 type: Non-legislative basic document published body: EC commission:
      • date: 2014-07-17T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s)
      • date: 2014-09-16T00:00:00 body: EP/CSL type: Initial period for examining delegated act extended at Parliament's request by 2 month(s)
      • date: 2014-09-17T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
      committees
      • body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
      links
      other
        procedure
        dossier_of_the_committee
        ENVI/8/00856
        reference
        2014/2759(DEA)
        title
        Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use
        stage_reached
        Awaiting committee decision
        summary
        Supplementing
        subtype
        Examination of delegated act
        type
        DEA - Delegated acts procedure
        subject
        4.20.04 Pharmaceutical products and industry